Toyoda H - Search Results

1

Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.

Uojima H, Yamasaki K, Sugiyama M, Kage M, Ishii N, Shirabe K, Hidaka H, Kusano C, Murakawa M, Asahina Y, Nishimura T, Iijima H, Sakamoto K, Ito K, Amano K, Kawaguchi T, Tamaki N, Kurosaki M, Suzuki T, Matsuura K, Taketomi A, Joshita S, Umemura T, Nishina S, Hino K, Toyoda H, Yatsuhashi H, Mizokami M. Uojima H, et al. Among authors: toyoda h. J Gastroenterol. 2024 Apr 16. doi: 10.1007/s00535-024-02100-3. Online ahead of print. J Gastroenterol. 2024. PMID: 38625546

2

Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy.

Hayashi K, Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Toyoda H, Shimizu H, Honda T. Hayashi K, et al. Among authors: toyoda h. Hepatogastroenterology. 2002 Mar-Apr;49(44):508-12. Hepatogastroenterology. 2002. PMID: 11995484

3

Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Toyoda H, et al. Am J Gastroenterol. 2005 Aug;100(8):1764-71. doi: 10.1111/j.1572-0241.2005.41943.x. Am J Gastroenterol. 2005. PMID: 16086713

4

Impact of hepatitis B virus integration into liver tissue on the efficacy of peginterferon and ribavirin therapy in hepatitis B virus-negative chronic hepatitis C patients.

Toyoda H, Kumada T, Tada T, Murakami Y. Toyoda H, et al. J Clin Gastroenterol. 2014 Jan;48(1):73-9. doi: 10.1097/MCG.0b013e31829c409d. J Clin Gastroenterol. 2014. PMID: 23842217 Clinical Trial.

5

Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.

Ito K, Yotsuyanagi H, Yatsuhashi H, Karino Y, Takikawa Y, Saito T, Arase Y, Imazeki F, Kurosaki M, Umemura T, Ichida T, Toyoda H, Yoneda M, Mita E, Yamamoto K, Michitaka K, Maeshiro T, Tanuma J, Tanaka Y, Sugiyama M, Murata K, Masaki N, Mizokami M; Japanese AHB Study Group. Ito K, et al. Among authors: toyoda h. Hepatology. 2014 Jan;59(1):89-97. doi: 10.1002/hep.26635. Epub 2013 Nov 20. Hepatology. 2014. PMID: 23897861

6

Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness.

Hayashi K, Katano Y, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2015 Jan;30(1):178-83. doi: 10.1111/jgh.12673. J Gastroenterol Hepatol. 2015. PMID: 24995561

7

Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

Honda T, Ishigami M, Masuda H, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Urano F, Yoshioka K, Toyoda H, Kumada T, Katano Y, Goto H. Honda T, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2015 Feb;30(2):321-8. doi: 10.1111/jgh.12703. J Gastroenterol Hepatol. 2015. PMID: 25091027

8

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.

Omata M, Nishiguchi S, Ueno Y, Mochizuki H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, Umemura T, Takehara T, Sakamoto N, Nishigaki Y, Nakane K, Toda N, Ide T, Yanase M, Hino K, Gao B, Garrison KL, Dvory-Sobol H, Ishizaki A, Omote M, Brainard D, Knox S, Symonds WT, McHutchison JG, Yatsuhashi H, Mizokami M. Omata M, et al. Among authors: toyoda h. J Viral Hepat. 2014 Nov;21(11):762-8. doi: 10.1111/jvh.12312. Epub 2014 Sep 8. J Viral Hepat. 2014. PMID: 25196837 Clinical Trial.

9

Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy.

Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabtake S, Ito T. Tada T, et al. Among authors: toyoda h. J Gastroenterol. 2015 Jul;50(7):795-804. doi: 10.1007/s00535-014-1011-6. Epub 2014 Nov 7. J Gastroenterol. 2015. PMID: 25376770

10

Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.

Toyoda H, Kumada T, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Ito T. Toyoda H, et al. J Gastroenterol Hepatol. 2015 Jul;30(7):1183-9. doi: 10.1111/jgh.12915. J Gastroenterol Hepatol. 2015. PMID: 25678094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,446 results

Search Page